Leap Therapeutics
LPTX
#10081
Rank
NZ$19.57 M
Marketcap
$0.47
Share price
-15.52%
Change (1 day)
-88.60%
Change (1 year)

Revenue for Leap Therapeutics (LPTX)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Leap Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A-100%
2021 NZ$2.19 M5.64%
2020 NZ$2.07 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA